Loading…
Mangoceuticals, Inc. is projected to rise to $0.7845 by 2027, a +58% move from its current price of $0.4957. MGRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.4556 | $0.4964 | $0.5408 | +0.13% |
| May 30 | $0.4403 | $0.497 | $0.5611 | +0.27% |
| May 31 | $0.429 | $0.4977 | $0.5774 | +0.40% |
| Jun 1 | $0.4198 | $0.4984 | $0.5916 | +0.54% |
| Jun 2 | $0.412 | $0.499 | $0.6045 | +0.67% |
| Jun 3 | $0.405 | $0.4997 | $0.6165 | +0.80% |
| Jun 4 | $0.3988 | $0.5004 | $0.6278 | +0.94% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3988 | $0.5004 | $0.6278 | +0.94% |
| Week 2 | $0.3664 | $0.5051 | $0.6961 | +1.89% |
| Week 3 | $0.3442 | $0.5098 | $0.7552 | +2.84% |
| Week 4 | $0.3269 | $0.5146 | $0.81 | +3.81% |
| Week 5 | $0.3128 | $0.5194 | $0.8626 | +4.79% |
| Week 6 | $0.3008 | $0.5243 | $0.9139 | +5.77% |
| Week 7 | $0.2904 | $0.5292 | $0.9645 | +6.76% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Mangoceuticals, Inc. operates in the Healthcare sector, focusing on the development, marketing, and sale of various men’s wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand.
It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand, and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas, operating as a subsidiary of Cohen Enterprises, Inc.
Mangoceuticals, Inc. (MGRX) currently trades around $0.4957 per share. The company has a market capitalization of $8.51M and holds a rank of 5140 by market size. The price outlook reflects a path that, in the near term, mirrors the current level but projects a bullish multi-year trajectory with rising averages and higher potential highs according to the provided forecast.
By 2030 and into the 2040s, forecasted averages and maximums imply meaningful upside from today's price.
A major floor 67.3% below — a decisive break under it would weaken the trend.
The nearest floor, 35.8% below — buyers have tended to step in here.
The nearest ceiling, 10.6% above — a clean break opens room to run.
A major ceiling 38.0% above — clearing it would confirm fresh momentum.
Key MGRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MGRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.472 | Buy | $0.4784 | Buy |
| MA 10 | $0.4351 | Buy | $0.4484 | Buy |
| MA 20 | $0.3934 | Buy | $0.4214 | Buy |
| MA 50 | $0.3867 | Buy | $0.4233 | Buy |
| MA 100 | $0.4467 | Buy | $0.5755 | Sell |
| MA 200 | $1.11 | Sell | $1.04 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.15 | Neutral |
| Stoch RSI (14) | 66.27 | Neutral |
| CCI (20) | 132.56 | Buy |
| Williams %R (14) | -25.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 20.68 | Buy |
| Bollinger %B (20,2) | 0.92 | Neutral |
| Stochastic %K (14) | 75.00 | Neutral |
| TRIX (15) | 0.37 | Buy |
| Awesome (5,34) | 0.07 | Buy |
| Ultimate (7,14,28) | 61.25 | Neutral |
| Momentum (10) | 0.15 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 0.51 | Sell |
| ADX (14) | 12.05 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture shows bullish sentiment with RSI(14) at 60. The near-term moving average picture features a SMA50 of $0.3867 and a SMA200 of $1.11, indicating a mixture of advancing momentum and longer-term resistance. Support is noted at $0.318 and resistance at $0.548, with the 30-day range spanning from $0.2817 to $0.8723, highlighting notable volatility as seen in the wide range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.162 | $0.4957 | $0.8735 | 0% | Neutral | |
| $0.5646 | $0.7845 | $1.18 | +58% | Bullish | |
| $0.5984 | $0.8824 | $1.41 | +78% | Bullish | |
| $0.5637 | $0.875 | $1.47 | +77% | Bullish | |
| $0.4637 | $0.7542 | $1.31 | +52% | Bullish | |
| $0.4244 | $0.7213 | $1.30 | +46% | Bullish | |
| $0.4165 | $0.7381 | $1.37 | +49% | Bullish | |
| $0.5328 | $0.9833 | $1.88 | +98% | Bullish | |
| $0.6064 | $1.16 | $2.28 | +135% | Bullish | |
| $0.5515 | $1.10 | $2.20 | +122% | Bullish | |
| $0.6552 | $1.46 | $3.20 | +194% | Bullish | |
| $1.03 | $2.29 | $5.27 | +363% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.162 | $0.4957 | $0.5985 | +0.00% |
| June 2026 | $0.4673 | $0.5605 | $0.6965 | +13.06% |
| July 2026 | $0.4591 | $0.5599 | $0.7136 | -0.10% |
| August 2026 | $0.4657 | $0.5756 | $0.7478 | +2.80% |
| September 2026 | $0.5117 | $0.6395 | $0.8439 | +11.10% |
| October 2026 | $0.5191 | $0.6554 | $0.8771 | +2.49% |
| November 2026 | $0.4868 | $0.6203 | $0.8402 | -5.36% |
| December 2026 | $0.4961 | $0.6376 | $0.8735 | +2.79% |
Click any year to see its month-by-month MGRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MGRX to range from $0.162 to $0.8735 through 2026. The $0.4957 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The MGRX price prediction for 2027 points to an average of $0.7845 (low $0.5646, high $1.18) — a potential gain of +58% on today's $0.4957. Momentum favours further upside here.
In 2028, MGRX is projected to trade between $0.5984 and $1.41, averaging $0.8824 — a potential gain of +78% from today's $0.4957. That is up +12% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Mangoceuticals, Inc.'s 2029 outlook centres on $0.875, within a $0.5637 to $1.47 range. That is -1% versus the projected 2028 average. That marks a +77% change versus current levels. Momentum favours further upside here.
By 2030, MGRX could reach as high as $1.31, with a base case around $0.7542 and support toward $0.4637 — roughly +52% from $0.4957. Buyers look set to stay in control over this stretch.
Expect MGRX to range from $0.4244 to $1.30 through 2031. The $0.7213 average target implies a +46% move from current prices. That is -4% versus the projected 2030 average. Momentum favours further upside here.
The MGRX price prediction for 2032 points to an average of $0.7381 (low $0.4165, high $1.37) — a potential gain of +49% on today's $0.4957. Buyers look set to stay in control over this stretch.
In 2033, MGRX is projected to trade between $0.5328 and $1.88, averaging $0.9833 — a potential gain of +98% from today's $0.4957. That is up +33% on the projected 2032 average. Momentum favours further upside here.
Mangoceuticals, Inc.'s 2034 outlook centres on $1.16, within a $0.6064 to $2.28 range. That is up +18% on the projected 2033 average. That marks a +135% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, MGRX could reach as high as $2.20, with a base case around $1.10 and support toward $0.5515 — roughly +122% from $0.4957. Momentum favours further upside here.
Expect MGRX to range from $0.6552 to $3.20 through 2040. The $1.46 average target implies a +194% move from current prices. That is up +32% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The MGRX price prediction for 2050 points to an average of $2.29 (low $1.03, high $5.27) — a potential gain of +363% on today's $0.4957. Momentum favours further upside here.
Investing $1,000 in MGRX today (≈ 2,017.349203 MGRX) could be worth
$4,625.37
+$3,625.37 (+363%) by 2050 · US Dollar
Based on the average projected MGRX price of $2.29 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MGRXwould be worth at today's price.
$1,000 invested in MGRX on May 27, 2025 (≈ 529.100533 MGRX) would be worth
$262.28
-$737.72 (-73.8%) today · 0.26× · US Dollar
Based on a MGRX entry price of $1.89 vs. today's $0.4957.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.427 | $1,160.89 | +16.1% |
| 1 month ago | $0.4 | $1,239.25 | +23.9% |
| 3 months ago | $0.519 | $955.11 | -4.5% |
| 6 months ago | $1.11 | $446.58 | -55.3% |
| 1 year ago | $1.89 | $262.28 | -73.8% |
| All time (3.2y) ago | $60 | $8.26 | -99.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MGRX forecast.
Our base-case forecast reaches $0.99 around 2034.
Implied market cap at $0.99: $17M
Longer-term forecasts illustrate a bullish trajectory across multiple years, with the average price rising from $0.4957 in 2026 to higher levels in subsequent years. Notable milestones include a 2027 average of $0.7845 and a 2033 average of $0.9833, as well as a 2040 average of $1.46 and a 2050 average of $2.29. The associated ROI figures show meaningful upside, including 58.3% in 2027, 78% in 2028, 76.5% in 2029, 52.1% in 2030, 45.5% in 2031, 48.9% in 2032, 98.4% in 2033, 134.8% in 2034, 122% in 2035, 193.7% in 2040, and a projected 362.5% by 2050.
The sentiment remains BULLISH across many years, though the forecast also indicates variability in annual returns and emphasizes that these are estimates, not guarantees. The asset is also associated with an annualized volatility of 200%.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $0.7542 with a minimum of $0.4637 and a maximum of $1.31, and an estimated ROI of 52.1% with a BULLISH sentiment.
Forecasts indicate bullish sentiment in multiple years, with averages rising to as high as $2.29 by 2050 and a maximum of $5.27, delivering ROI up to 362.5% in 2050. However, these are estimates and not guarantees, and near-term results may vary.
Yes. The forecast shows several years with expectations above $1: 2029 max $1.47, 2030 max $1.31, 2033 max $1.88, and 2034 max $2.28, among others, reflecting potential upside beyond the $1 level.
The 2040 forecast lists an average price of $1.46 with a maximum of $3.20 and an ROI of 193.7%, with a BULLISH sentiment.
Mangoceuticals, Inc. Community Discussion
0Share your Mangoceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.